Free Trial
→ Your book is inside (From Profits Run) (Ad)tc pixel Free MXCT Stock Alerts

MaxCyte (MXCT) Competitors

MaxCyte logo
GBX 1.22 +0.01 (+0.83%)
As of 06/1/2026
Compare

MXCT vs. ADV, MAST, ABM, RGP, and LEAF

Should you buy MaxCyte stock or one of its competitors? MarketBeat compares MaxCyte with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with MaxCyte include Advance Energy (ADV), MAST Energy Developments (MAST), African Battery Metals (ABM), Ross Group (RGP), and Leaf Clean Energy (LEAF). These companies are all part of the "business services" industry.

How does MaxCyte compare to Advance Energy?

MaxCyte (LON:MXCT) and Advance Energy (LON:ADV) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and risk.

24.0% of MaxCyte shares are held by institutional investors. 1.9% of MaxCyte shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Advance Energy has lower revenue, but higher earnings than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than Advance Energy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MaxCyte£32.29M0.04-£45.08M-£40.00N/A
Advance Energy£16K0.00N/A-£0.60N/A

Advance Energy has a net margin of 0.00% compared to MaxCyte's net margin of -120.39%. Advance Energy's return on equity of 0.00% beat MaxCyte's return on equity.

Company Net Margins Return on Equity Return on Assets
MaxCyte-120.39% -16.71% -11.07%
Advance Energy N/A N/A N/A

In the previous week, Advance Energy had 1 more articles in the media than MaxCyte. MarketBeat recorded 1 mentions for Advance Energy and 0 mentions for MaxCyte. MaxCyte's average media sentiment score of 0.00 equaled Advance Energy'saverage media sentiment score.

Company Overall Sentiment
MaxCyte Neutral
Advance Energy Neutral

Summary

Advance Energy beats MaxCyte on 5 of the 9 factors compared between the two stocks.

How does MaxCyte compare to MAST Energy Developments?

MAST Energy Developments (LON:MAST) and MaxCyte (LON:MXCT) are both small-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

0.2% of MAST Energy Developments shares are held by institutional investors. Comparatively, 24.0% of MaxCyte shares are held by institutional investors. 3.5% of MAST Energy Developments shares are held by company insiders. Comparatively, 1.9% of MaxCyte shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, MAST Energy Developments' average media sentiment score of 0.00 equaled MaxCyte'saverage media sentiment score.

Company Overall Sentiment
MAST Energy Developments Neutral
MaxCyte Neutral

MAST Energy Developments has a beta of -0.58, suggesting that its share price is 158% less volatile than the broader market. Comparatively, MaxCyte has a beta of 1.13, suggesting that its share price is 13% more volatile than the broader market.

MAST Energy Developments has higher earnings, but lower revenue than MaxCyte. MAST Energy Developments is trading at a lower price-to-earnings ratio than MaxCyte, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MAST Energy Developments£1.26M1.63-£3.26M-£13.60N/A
MaxCyte£32.29M0.04-£45.08M-£40.00N/A

MAST Energy Developments has a net margin of 0.00% compared to MaxCyte's net margin of -120.39%. MaxCyte's return on equity of -16.71% beat MAST Energy Developments' return on equity.

Company Net Margins Return on Equity Return on Assets
MAST Energy DevelopmentsN/A -695.03% -14.56%
MaxCyte -120.39%-16.71%-11.07%

Summary

MaxCyte beats MAST Energy Developments on 6 of the 11 factors compared between the two stocks.

How does MaxCyte compare to African Battery Metals?

MaxCyte (LON:MXCT) and African Battery Metals (LON:ABM) are both small-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations and earnings.

African Battery Metals has a net margin of 0.00% compared to MaxCyte's net margin of -120.39%. African Battery Metals' return on equity of 0.00% beat MaxCyte's return on equity.

Company Net Margins Return on Equity Return on Assets
MaxCyte-120.39% -16.71% -11.07%
African Battery Metals N/A N/A N/A

24.0% of MaxCyte shares are owned by institutional investors. 1.9% of MaxCyte shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, MaxCyte's average media sentiment score of 0.00 equaled African Battery Metals'average media sentiment score.

Company Overall Sentiment
MaxCyte Neutral
African Battery Metals Neutral

African Battery Metals has lower revenue, but higher earnings than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than African Battery Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MaxCyte£32.29M0.04-£45.08M-£40.00N/A
African Battery MetalsN/AN/AN/A-£4.50N/A

Summary

MaxCyte and African Battery Metals tied by winning 4 of the 8 factors compared between the two stocks.

How does MaxCyte compare to Ross Group?

MaxCyte (LON:MXCT) and Ross Group (LON:RGP) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings.

MaxCyte has a beta of 1.13, indicating that its stock price is 13% more volatile than the broader market. Comparatively, Ross Group has a beta of 0.03, indicating that its stock price is 97% less volatile than the broader market.

Ross Group has lower revenue, but higher earnings than MaxCyte.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MaxCyte£32.29M0.04-£45.08M-£40.00N/A
Ross Group£43K0.00-£3.18MN/AN/A

Ross Group has a net margin of 0.00% compared to MaxCyte's net margin of -120.39%. Ross Group's return on equity of 0.00% beat MaxCyte's return on equity.

Company Net Margins Return on Equity Return on Assets
MaxCyte-120.39% -16.71% -11.07%
Ross Group N/A N/A -131.93%

In the previous week, MaxCyte's average media sentiment score of 0.00 equaled Ross Group'saverage media sentiment score.

Company Overall Sentiment
MaxCyte Neutral
Ross Group Neutral

24.0% of MaxCyte shares are owned by institutional investors. 1.9% of MaxCyte shares are owned by insiders. Comparatively, 21.0% of Ross Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

MaxCyte beats Ross Group on 5 of the 9 factors compared between the two stocks.

How does MaxCyte compare to Leaf Clean Energy?

Leaf Clean Energy (LON:LEAF) and MaxCyte (LON:MXCT) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, risk and profitability.

Leaf Clean Energy has higher earnings, but lower revenue than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than Leaf Clean Energy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Leaf Clean Energy-£2M0.00N/A£142.80N/A
MaxCyte£32.29M0.04-£45.08M-£40.00N/A

Leaf Clean Energy has a net margin of 0.00% compared to MaxCyte's net margin of -120.39%. Leaf Clean Energy's return on equity of 0.00% beat MaxCyte's return on equity.

Company Net Margins Return on Equity Return on Assets
Leaf Clean EnergyN/A N/A N/A
MaxCyte -120.39%-16.71%-11.07%

24.0% of MaxCyte shares are owned by institutional investors. 1.9% of MaxCyte shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Leaf Clean Energy's average media sentiment score of 0.00 equaled MaxCyte'saverage media sentiment score.

Company Overall Sentiment
Leaf Clean Energy Neutral
MaxCyte Neutral

Summary

Leaf Clean Energy beats MaxCyte on 5 of the 8 factors compared between the two stocks.

Get MaxCyte News Delivered to You Automatically

Sign up to receive the latest news and ratings for MXCT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MXCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MXCT vs. The Competition

Export
MetricMaxCyteMedical Devices IndustryMedical SectorLON Exchange
Market Cap£1.30M£2.07B£6.24B£2.79B
Dividend YieldN/A2.68%2.69%6.13%
P/E Ratio-0.0314.2121.09364.80
Price / Sales0.04122.10561.4587,613.72
Price / Cash1.9715.9942.3127.85
Price / Book0.014.379.957.84
Net Income-£45.08M£144.75M£3.56B£5.88B
7 Day Performance22.00%1.83%-0.07%6.67%
1 Month Performance38.64%0.45%5.08%9.91%
1 Year Performance-99.25%5.70%28.39%75.85%

MaxCyte Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MXCT
MaxCyte
N/AGBX 1.22
+0.8%		N/A-99.3%£1.30M£32.29MN/A80
ADV
Advance Energy
N/AN/AN/AN/A£2.67M£16KN/A75,000
MAST
MAST Energy Developments
N/AGBX 1.20
flat		N/A+38.4%£2.06M£1.26MN/A29,900
ABM
African Battery Metals
N/AN/AN/AN/A£2.00MN/AN/A127,000
RGP
Ross Group
N/AN/AN/AN/A£1.63M£43KN/A4,260

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:MXCT) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel